Literature DB >> 21725241

The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

Maura L Furey1.   

Abstract

PURPOSE OF REVIEW: The present review develops a framework from which to understand the role of the cholinergic system in healthy cognition and in cognitive dysfunction. Traditionally, the cholinergic system has been thought to have direct influence on cognitive processes such as working memory and attention. Although the influence of cholinergic function on stimulus processing has been long appreciated, the notion that cholinergic effects on stimulus processing is the mechanism by which acetylcholine influences cognitive processes has only more recently been considered. RECENT
FINDINGS: Literature supporting the hypothesis that cholinergic modulation influences cognitive functions through stimulus processing mechanisms has been growing for over a decade. Recent conceptualizations of the developing literature have argued for a new interpretation to an old and developing literature.
SUMMARY: The argument that cholinergic function modulates cognitive processes by direct effects on basic stimulus processing extends to cognitive dysfunction in neuropathological conditions including dementia and mood disorders. Memory and attention deficits observed in these and other conditions can be understood by evaluating the impact of cholinergic dysfunction on stimulus processing, rather than on the cognitive function in general.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725241      PMCID: PMC3264402          DOI: 10.1097/WCO.0b013e328348bda5

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  101 in total

Review 1.  Two-stage model of memory trace formation: a role for "noisy" brain states.

Authors:  G Buzsáki
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

2.  Pathophysiology of "cholinoceptor supersensitivity" in affective disorders.

Authors:  S C Dilsaver
Journal:  Biol Psychiatry       Date:  1986-07       Impact factor: 13.382

3.  Dementia and working memory.

Authors:  A Baddeley; R Logie; S Bressi; S Della Sala; H Spinnler
Journal:  Q J Exp Psychol A       Date:  1986-11

4.  Construct accessibility and clinical depression: a longitudinal investigation.

Authors:  I H Gotlib; D B Cane
Journal:  J Abnorm Psychol       Date:  1987-08

5.  The effects of scopolamine on working memory in healthy young volunteers.

Authors:  J M Rusted; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  The aging human brain.

Authors:  H Creasey; S I Rapoport
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

7.  Selective attention gates visual processing in the extrastriate cortex.

Authors:  J Moran; R Desimone
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

8.  A functional role of cholinergic innervation to neurons in the cat visual cortex.

Authors:  H Sato; Y Hata; H Masui; T Tsumoto
Journal:  J Neurophysiol       Date:  1987-10       Impact factor: 2.714

Review 9.  Pharmacologic modelling of Alzheimer's disease.

Authors:  T Sunderland; P N Tariot; H Weingartner; D L Murphy; P A Newhouse; E A Mueller; R M Cohen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1986       Impact factor: 5.067

10.  Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine.

Authors:  C L Murray; H C Fibiger
Journal:  Neuroscience       Date:  1985-04       Impact factor: 3.590

View more
  17 in total

Review 1.  Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Authors:  Maura L Furey; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

2.  Event-related oscillations (ERO) during an active discrimination task: Effects of lesions of the nucleus basalis magnocellularis.

Authors:  Manuel Sanchez-Alavez; Cindy L Ehlers
Journal:  Int J Psychophysiol       Date:  2015-02-07       Impact factor: 2.997

Review 3.  A biased competition account of attention and memory in Alzheimer's disease.

Authors:  Kathrin Finke; Nicholas Myers; Peter Bublak; Christian Sorg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-09       Impact factor: 6.237

4.  Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention.

Authors:  Emiliano Ricciardi; Giacomo Handjaras; Giulio Bernardi; Pietro Pietrini; Maura L Furey
Journal:  Neuropharmacology       Date:  2012-08-18       Impact factor: 5.250

Review 5.  Human biomarkers of rapid antidepressant effects.

Authors:  Carlos A Zarate; Daniel C Mathews; Maura L Furey
Journal:  Biol Psychiatry       Date:  2013-01-29       Impact factor: 13.382

Review 6.  Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.

Authors:  Wayne C Drevets; Carlos A Zarate; Maura L Furey
Journal:  Biol Psychiatry       Date:  2012-11-28       Impact factor: 13.382

7.  Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder.

Authors:  Joanna Szczepanik; Allison C Nugent; Wayne C Drevets; Ashish Khanna; Carlos A Zarate; Maura L Furey
Journal:  Psychiatry Res Neuroimaging       Date:  2016-06-20       Impact factor: 2.376

8.  Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.

Authors:  Maura L Furey; Wayne C Drevets; Elana M Hoffman; Erica Frankel; Andrew M Speer; Carlos A Zarate
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

Review 9.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

10.  Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.

Authors:  Maura L Furey; Wayne C Drevets; Joanna Szczepanik; Ashish Khanna; Allison Nugent; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2015-03-28       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.